Immatics (IMTX) FCF Margin Growth (1y) (2020 - 2025)
Immatics (IMTX) FCF Margin Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,187.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - | -19,099.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19,099.00 |
| Sep 30, 2025 | -77,968.00 |
| Jun 30, 2025 | -63,118.00 |
| Mar 31, 2025 | -9,012.00 |
| Dec 31, 2024 | -26,913.00 |
| Sep 30, 2024 | 34,423.00 |
| Jun 30, 2024 | -18,139.00 |
| Mar 31, 2024 | 12,061.00 |
| Dec 31, 2023 | 27,594.00 |
| Sep 30, 2023 | -25,422.00 |
| Jun 30, 2023 | -26,750.00 |
| Mar 31, 2023 | -30,350.00 |
| Dec 31, 2022 | 4,122.00 |
| Sep 30, 2022 | 18,276.00 |
| Jun 30, 2022 | 96,517.00 |
| Mar 31, 2022 | 32,285.00 |
| Dec 31, 2021 | 21,215.00 |
| Sep 30, 2021 | 5,707.00 |
| Jun 30, 2021 | -47,414.00 |
| Mar 31, 2021 | -8,856.00 |